132 related articles for article (PubMed ID: 35871976)
21. Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
Bozdogan ST; Mujde C; Boga I; Sonmezler O; Hanta A; Rencuzogullari C; Ozcan D; Altintas DU; Bisgin A
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572515
[TBL] [Abstract][Full Text] [Related]
22. Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process.
Munck A; Delmas D; Audrézet MP; Lemonnier L; Cheillan D; Roussey M
J Med Screen; 2018 Mar; 25(1):6-12. PubMed ID: 28454512
[TBL] [Abstract][Full Text] [Related]
23. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
[TBL] [Abstract][Full Text] [Related]
24. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
Padoan R; Bassotti A; Seia M; Corbetta C
Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
[TBL] [Abstract][Full Text] [Related]
25. Immunoreactive trypsinogen in healthy newborns and infants with cystic fibrosis.
Fingerhut R; Rueegg CS; Imahorn O; Pedersen ESL; Kuehni CE; Gallati S; Regamey N; Barben J
Arch Dis Child Fetal Neonatal Ed; 2023 Mar; 108(2):176-181. PubMed ID: 36351789
[TBL] [Abstract][Full Text] [Related]
26. Cystic fibrosis newborn screening: Five-year experience from a tertiary care center.
Nayir Buyuksahin H; Emiralioglu N; Ozsezen B; Ademhan Tural D; Sunman B; Guzelkas I; Tezel B; Dayangaç Erden D; Yalçın E; Dogru D; Ozcelik U; Kiper N
Pediatr Pulmonol; 2022 Feb; 57(2):403-410. PubMed ID: 34842364
[TBL] [Abstract][Full Text] [Related]
27. Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants.
Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
J Cyst Fibros; 2015 Nov; 14(6):714-9. PubMed ID: 25824995
[TBL] [Abstract][Full Text] [Related]
28. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.
Sommerburg O; Lindner M; Muckenthaler M; Kohlmueller D; Leible S; Feneberg R; Kulozik AE; Mall MA; Hoffmann GF
J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S263-71. PubMed ID: 20714932
[TBL] [Abstract][Full Text] [Related]
29. Two years of newborn screening for cystic fibrosis in Turkey: Çukurova experience.
Şaşihüseyinoğlu AŞ; Altıntaş DU; Bişgin A; Doğruel D; Yılmaz M; Serbes M
Turk J Pediatr; 2019; 61(4):505-512. PubMed ID: 31990467
[TBL] [Abstract][Full Text] [Related]
30. Cystic fibrosis infant care challenges in diagnosis and management in the era of newborn screening.
Padman R; Flathers K; Passi V
Del Med J; 2012 May; 84(5):149-55. PubMed ID: 22866385
[TBL] [Abstract][Full Text] [Related]
31. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
[TBL] [Abstract][Full Text] [Related]
32. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
[TBL] [Abstract][Full Text] [Related]
33. Differences in clinical condition and genotype at time of diagnosis of cystic fibrosis by newborn screening or by symptoms.
Vernooij-van Langen AM; Gerzon FL; Loeber JG; Dompeling E; Dankert-Roelse JE
Mol Genet Metab; 2014; 113(1-2):100-4. PubMed ID: 25077434
[TBL] [Abstract][Full Text] [Related]
34. Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.
Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
PLoS One; 2016; 11(5):e0155624. PubMed ID: 27214204
[TBL] [Abstract][Full Text] [Related]
35. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres.
Terlizzi V; Claut L; Tosco A; Colombo C; Raia V; Fabrizzi B; Lucarelli M; Angeloni A; Cimino G; Castaldo A; Marsiglio L; Timpano S; Cirilli N; Moroni L; Festini F; Piccinini P; Zavataro L; Bonomi P; Taccetti G; Southern KW; Padoan R
J Cyst Fibros; 2021 Sep; 20(5):828-834. PubMed ID: 33883100
[TBL] [Abstract][Full Text] [Related]
36. Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities.
McGarry ME; Sciortino S; Graham S; Bishop T; Gibb ER
Pediatr Pulmonol; 2024 Jun; ():. PubMed ID: 38940324
[TBL] [Abstract][Full Text] [Related]
37. Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.
Munck A; Bourmaud A; Bellon G; Picq P; Farrell PM;
Pediatr Pulmonol; 2020 Apr; 55(4):918-928. PubMed ID: 31916691
[TBL] [Abstract][Full Text] [Related]
38. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
Tluczek A; Koscik RL; Farrell PM; Rock MJ
Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
[TBL] [Abstract][Full Text] [Related]
39. Buccal cell DNA mutation analysis for diagnosis of cystic fibrosis in newborns and infants inaccessible to sweat chloride measurement.
Parad RB
Pediatrics; 1998 May; 101(5):851-5. PubMed ID: 9565413
[TBL] [Abstract][Full Text] [Related]
40. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
